Literature DB >> 30623825

Large-scale roll out of electronic longitudinal mood-monitoring for research in affective disorders: Report from the UK bipolar disorder research network.

Katherine Gordon-Smith1, Kate Saunders2, John R Geddes2, Paul J Harrison2, Chris Hinds2, Nick Craddock3, Ian Jones3, Lisa Jones4.   

Abstract

BACKGROUND: Electronic longitudinal mood monitoring has been shown to be acceptable to patients with affective disorders within clinical settings, but its use in large-scale research has not yet been established.
METHODS: Using both postal and email invitations, we invited 4080 past research participants with affective disorders who were recruited into the Bipolar Disorder Research Network (BDRN) over a 10 year period to participate in online weekly mood monitoring. In addition, since January 2015 we have invited all newly recruited BDRN research participants to participate in mood monitoring at the point they were recruited into BDRN.
RESULTS: Online mood monitoring uptake among past participants was 20%, and among new participants to date was 46% with participants recruited over the last year most likely to register (61%). More than 90% mood monitoring participants engaged for at least one month, with mean engagement period greater than one year (58 weeks) and maximum engagement for longer than three years (165 weeks). There were no significant differences in the proportion of past and new BDRN participants providing data for at least 4 weeks (91%, 92% respectively), 3 months (78%, 82%), 6 months (65%, 54%) or one year (51%, 44%). LIMITATIONS: Our experiences with recruiting participants for electronic prospective mood monitoring may not necessarily generalise fully to research situations that are very different from those we describe.
CONCLUSIONS: Large-scale electronic longitudinal mood monitoring in affective disorders for research purposes is feasible with uptake highest among newly recruited participants.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Affective disorder; Longitudinal; Mood monitoring; Online data collection

Mesh:

Year:  2018        PMID: 30623825     DOI: 10.1016/j.jad.2018.12.099

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Bipolar II Disorder Is NOT a Myth.

Authors:  Andrew A Nierenberg
Journal:  Can J Psychiatry       Date:  2019-08       Impact factor: 4.356

2.  Smartphones and Wearables as a Method for Understanding Symptom Mechanisms.

Authors:  Benjamin Griffin; Kate E A Saunders
Journal:  Front Psychiatry       Date:  2020-01-17       Impact factor: 4.157

3.  The True Colours Remote Symptom Monitoring System: A Decade of Evolution.

Authors:  Sarah M Goodday; Mary-Jane Attenburrow; Lauren Atkinson; Guy Goodwin; Kate Saunders; Matthew South; Clare Mackay; Mike Denis; Chris Hinds; Jim Davies; James Welch; William Stevens; Karen Mansfield; Juulia Suvilehto; John Geddes
Journal:  J Med Internet Res       Date:  2020-01-15       Impact factor: 5.428

4.  Item-level analysis of mental health symptom trajectories during the COVID-19 pandemic in the UK: Associations with age, sex and pre-existing psychiatric conditions.

Authors:  Adam Hampshire; William Trender; Jon E Grant; M Berk Mirza; Rosalyn Moran; Peter J Hellyer; Samuel R Chamberlain
Journal:  Compr Psychiatry       Date:  2022-01-31       Impact factor: 3.735

5.  Mental health prior to and during the COVID-19 pandemic in individuals with bipolar disorder: Insights from prospective longitudinal data.

Authors:  Katie J S Lewis; Katherine Gordon-Smith; Kate E A Saunders; Clare Dolman; Matthew South; John Geddes; Nick Craddock; Arianna Di Florio; Ian Jones; Lisa Jones
Journal:  Bipolar Disord       Date:  2022-03-28       Impact factor: 5.345

6.  Mood Monitoring Over One Year for People With Chronic Obstructive Pulmonary Disease Using a Mobile Health System: Retrospective Analysis of a Randomized Controlled Trial.

Authors:  Maxine E Whelan; Carmelo Velardo; Heather Rutter; Lionel Tarassenko; Andrew J Farmer
Journal:  JMIR Mhealth Uhealth       Date:  2019-11-22       Impact factor: 4.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.